Overview

Topical Corticosteroids Market is forecasted to value over USD xx billion by 2027 end and register a CAGR of xx% from the forecast period 2020-2027.

FutureWise Market Research has illustrated a report on the Topical Corticosteroids Market. The report provides an in-depth anatomy of the market trends affecting its growth. Moreover, it includes intricate insights on profitability graph, market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of this market.

The Topical Corticosteroids market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Topical Corticosteroids market are    
• AstraZeneca plc
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Pfizer Inc.
• Sandoz AG (Novartis AG)
• Sanofi S.A.
• Actimis Pharmaceuticals
• Valeant Pharmaceuticals
• Almirall, S.A
• Zylera Pharmaceuticals
(Note: The list of the major players will be updated with the latest market scenario and trends)

Topical Corticosteroids Market Segmentation:
By Type of Formulation
• Ointments
• Creams
• Others
By Type of Potency
• Ultra High
• High
• Moderate
• Low
By Application
• Hospitals
• Dermatology Clinics
• Pharmacies
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Topical Corticosteroids market by type of Formulation, by type of Potency, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate the competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
          1.1 Objectives of the Study 
          1.2 Market Definition 
          1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
          1.4 Currency 
          1.5 Limitations 
          1.6 Stakeholders 
 2.  Research Methodology 
      2.1 Research Data 
         2.1.1 Secondary Data
                 2.1.1.1 Key Data From Secondary Sources
         2.1.2 Primary Data
                 2.1.2.1 Key Data From Primary Sources
      2.2 Market Size Estimation 
      2.3 Market Breakdown and Data Triangulation 
      2.4 Assumptions for the Study  
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Global Topical Corticosteroids Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Market Overview
     5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Topical Corticosteroids Market Analysis Tools
         6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Topical Corticosteroids Market, By Formulation Type Historical Analysis and Forecast 2020-2027 (USD Million)
           7.1. Ointments
           7.2. Creams
           7.3. Others
8. Global Topical Corticosteroids Market, By Potency Historical Analysis and Forecast 2020-2027 (USD Million)
           8.1. Ultra High
           8.2. High
           8.3. Moderate
           8.4. Low
9. Global Topical Corticosteroids Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
           9.1. Hospitals
           9.2. Dermatology Clinics
           9.3. Pharmacies
           9.4. Others
10.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs
     10.1. Introduction
     10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            10.2.1. U.S.A
            10.2.2. Canada
     10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
     11.1. Introduction
     11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            11.2.1. Germany
            11.2.2. U.K
            11.2.3. France
           11.2.4. Italy
           11.2.5. Spain
           11.2.6. Russia
           11.2.7. Poland
           11.2.8. Switzerland
           11.2.9.Rest of Western Europe
12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             12.2.1. Japan
             12.2.2. China
             12.2.3. Singapore
             12.2.4. India
             12.2.5. Australia and New Zealand
             12.2.6. ASEAN
             12.2.7. South Korea
             12.2.8. Rest of Asia Pacific
        12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
  13. Rest of the World Market Analysis 2015–2019 and Forecast
         2020–2027 (USD Million) along with expected regulatory needs
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             13.2.1. Saudi Arabia
             13.2.2. UAE
             13.2.3. South Africa
             13.2.4. Egypt
        13.3. Market Size (USD Million) Forecast for MEA 2020-2027
           
    14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
         14.1. AstraZeneca plc
                14.1.1. Company Overview
                14.1.2. Product Portfolio
                14.1.3. SWOT Analysis
                14.1.4. Financial Overview
                14.1.5. Strategic Overview
         14.2. GlaxoSmithKline plc
                14.2.1. Company Overview
                14.2.2. Product Portfolio
                14.2.3. SWOT Analysis
                14.2.4. Financial Overview
                14.2.5. Strategic Overview
         14.3. Merck & Co., Inc.
                14.3.1. Company Overview
                14.3.2. Product Portfolio
                14.3.3. SWOT Analysis
                14.3.4. Financial Overview
                14.3.5. Strategic Overview
         14.4. Pfizer Inc.
                14.4.1. Company Overview
                14.4.2. Product Portfolio
                14.4.3. SWOT Analysis
                14.4.4. Financial Overview
                14.4.5. Strategic Overview
         14.5. Sandoz AG (Novartis AG)
                13.5.1. Company Overview
                13.5.2. Product Portfolio
                13.5.3. SWOT Analysis
                13.5.4. Financial Overview
                13.5.5. Strategic Overview
         14.6. Sanofi S.A.
                14.6.1. Company Overview
                14.6.2. Product Portfolio
                14.6.3.  SWOT Analysis
                14.6.4. Financial Overview
                               14.6.5. Strategic Overview
         14.7. Actimis Pharmaceuticals
                14.7.1. Company Overview
                14.7.2. Product Portfolio
                14.7.3. SWOT Analysis
                14.7.4. Financial Overview
                14.7.5. Strategic Overview
         14.8. Valeant Pharmaceuticals
                14.8.1. Company Overview
                14.8.2. Product Portfolio
                14.8.3. SWOT Analysis
                14.8.4. Financial Overview
                14.8.5. Strategic Overview
         14.9. Almirall, S.A
                14.9.1. Company Overview
                14.9.2. Product Portfolio
                14.9.3. SWOT Analysis
                14.9.4. Financial Overview
                14.9.5. Strategic Overview
         14.10. Zylera Pharmaceuticals
                14.10.1. Company Overview
                14.10.2. Product Portfolio
                14.10.3.  SWOT Analysis
                14.10.4. Financial Overview
                14.10.5. Strategic Overview
15. FutureWise SME key takeaway points for Client

Tables

Figures